DK0482176T3 - Monoklonale antistoffer, der er specifikke for Toxin B Fra Clostridium difficile - Google Patents
Monoklonale antistoffer, der er specifikke for Toxin B Fra Clostridium difficileInfo
- Publication number
- DK0482176T3 DK0482176T3 DK91909906.9T DK91909906T DK0482176T3 DK 0482176 T3 DK0482176 T3 DK 0482176T3 DK 91909906 T DK91909906 T DK 91909906T DK 0482176 T3 DK0482176 T3 DK 0482176T3
- Authority
- DK
- Denmark
- Prior art keywords
- toxin
- monoclonal antibodies
- antibodies specific
- clostridium difficile
- difficile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1282—Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/522,881 US5231003A (en) | 1990-05-11 | 1990-05-11 | Monoclonal antibodies specific for toxin b of clostridium difficile |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0482176T3 true DK0482176T3 (da) | 1998-05-18 |
Family
ID=24082747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91909906.9T DK0482176T3 (da) | 1990-05-11 | 1991-05-06 | Monoklonale antistoffer, der er specifikke for Toxin B Fra Clostridium difficile |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5231003A (da) |
| EP (1) | EP0482176B1 (da) |
| JP (1) | JPH05500011A (da) |
| AT (1) | ATE160575T1 (da) |
| AU (1) | AU655586B2 (da) |
| CA (1) | CA2063709A1 (da) |
| DE (1) | DE69128273T2 (da) |
| DK (1) | DK0482176T3 (da) |
| ES (1) | ES2110993T3 (da) |
| IE (1) | IE911617A1 (da) |
| WO (1) | WO1991018293A1 (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610023A (en) * | 1995-03-31 | 1997-03-11 | Lee Laboratories, Inc. | Method of purification of clostridium difficile toxin A and production of mono-specific antibodies |
| US7179611B2 (en) * | 1997-02-10 | 2007-02-20 | Bd Lee Laboratories | Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A |
| US5965375A (en) * | 1997-04-04 | 1999-10-12 | Biosite Diagnostics | Diagnostic tests and kits for Clostridium difficile |
| DE19739685A1 (de) | 1997-09-10 | 1999-03-11 | Eichel Streiber Christoph Von | Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile |
| US6290946B1 (en) | 1999-05-13 | 2001-09-18 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders and antibacterial agents |
| US6270755B1 (en) | 1999-05-13 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders |
| CA2314494A1 (en) | 2000-05-02 | 2001-11-02 | Geltex Pharmaceuticals, Inc. | Anionic polymers as species specific antibacterial agents |
| EP1542706A1 (en) * | 2002-07-22 | 2005-06-22 | Genzyme Corporation | Poly (potassium and sodium styrene sulfonate), its manufacture and its uses |
| LT2857418T (lt) | 2004-02-06 | 2017-09-25 | University Of Massachusetts | Antikūnai prieš clostridium difficile toksinus ir jų panaudojimas |
| AU2005295708A1 (en) * | 2004-10-13 | 2006-04-27 | Relypsa, Inc. | Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle |
| US20060078534A1 (en) * | 2004-10-13 | 2006-04-13 | Dominique Charmot | Toxin binding compositions |
| CA2680741A1 (en) | 2007-03-22 | 2009-01-15 | The Regents Of The University Of California | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| WO2009108652A1 (en) | 2008-02-28 | 2009-09-03 | 3M Innovative Properties Company | Antibodies to clostridium difficile spores and uses thereof |
| WO2010014854A2 (en) | 2008-07-31 | 2010-02-04 | The Regents Of The University Of California | Antibodies that neutralize botulinum neurotoxins |
| CA2768528C (en) * | 2009-07-27 | 2017-05-23 | Christoph Von Eichel-Streiber | Method for detecting and identifying a variant c. difficile strain in a sample |
| KR101820987B1 (ko) * | 2010-04-15 | 2018-01-22 | 프로제닉스 파머슈티컬스, 인코포레이티드 | 클로스트리듐 디피실리 관련 감염 및 질병의 치료를 위한 항체 |
| US9243057B2 (en) | 2010-08-31 | 2016-01-26 | The Regents Of The University Of California | Antibodies for botulinum neurotoxins |
| AR086199A1 (es) | 2011-04-22 | 2013-11-27 | Wyeth Llc | Composiciones relacionadas con una toxina de clostridium difficile mutante y sus metodos |
| US9505847B2 (en) | 2011-08-22 | 2016-11-29 | Cnj Holdings Inc | Clostridium difficile antibodies |
| US8790880B2 (en) * | 2011-09-26 | 2014-07-29 | Techlab, Inc. | Cysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficile |
| HK1200463A1 (en) * | 2012-03-02 | 2015-08-07 | 瑞泽恩制药公司 | Human antibodies to clostridium difficile toxins |
| BR122016023101B1 (pt) | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile |
| EP4168032A2 (en) | 2020-06-19 | 2023-04-26 | Pfizer Inc. | Immunogenic compositions against clostridioides (clostridium) difficile and methods thereof |
| CN112812189B (zh) * | 2020-11-30 | 2022-05-17 | 四川大学华西医院 | 一种抗糖基转移酶a亚单位的纳米抗体及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4533630A (en) * | 1982-09-13 | 1985-08-06 | Wilkins Tracy D | Toxins and antibodies of C. difficile |
| US4879218A (en) * | 1982-09-13 | 1989-11-07 | Virginia Tech Intellectual Properties, Inc. | Antibody for C.difficile |
| EP0154064A1 (en) * | 1984-03-02 | 1985-09-11 | Tracy Dale Wilkins | Toxins and antibodies of C. difficile |
-
1990
- 1990-05-11 US US07/522,881 patent/US5231003A/en not_active Expired - Fee Related
-
1991
- 1991-05-06 CA CA002063709A patent/CA2063709A1/en not_active Abandoned
- 1991-05-06 DK DK91909906.9T patent/DK0482176T3/da active
- 1991-05-06 JP JP3509843A patent/JPH05500011A/ja active Pending
- 1991-05-06 AT AT91909906T patent/ATE160575T1/de active
- 1991-05-06 DE DE69128273T patent/DE69128273T2/de not_active Expired - Fee Related
- 1991-05-06 EP EP91909906A patent/EP0482176B1/en not_active Expired - Lifetime
- 1991-05-06 WO PCT/US1991/003108 patent/WO1991018293A1/en not_active Ceased
- 1991-05-06 AU AU78830/91A patent/AU655586B2/en not_active Ceased
- 1991-05-06 ES ES91909906T patent/ES2110993T3/es not_active Expired - Lifetime
- 1991-05-10 IE IE161791A patent/IE911617A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0482176A1 (en) | 1992-04-29 |
| CA2063709A1 (en) | 1991-11-12 |
| AU655586B2 (en) | 1995-01-05 |
| AU7883091A (en) | 1991-12-10 |
| WO1991018293A1 (en) | 1991-11-28 |
| EP0482176A4 (en) | 1992-08-05 |
| US5231003A (en) | 1993-07-27 |
| DE69128273D1 (de) | 1998-01-08 |
| ATE160575T1 (de) | 1997-12-15 |
| IE911617A1 (en) | 1991-11-20 |
| EP0482176B1 (en) | 1997-11-26 |
| JPH05500011A (ja) | 1993-01-14 |
| ES2110993T3 (es) | 1998-03-01 |
| DE69128273T2 (de) | 1998-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0482176T3 (da) | Monoklonale antistoffer, der er specifikke for Toxin B Fra Clostridium difficile | |
| FI914908A0 (fi) | Ny monoklonal antikropp med ny antigen relaterad till humana tumoerer. | |
| ES2110230T3 (es) | Ensayo de rapamicina. | |
| DK0528931T3 (da) | Humaniserede kimæriske anti-ICAM-1 antistoffer, fremgangsmåder til fremstilling deraf og anvendelse deraf | |
| DK0616613T3 (da) | Fragmenter af prionprotein | |
| MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
| FI900332A7 (fi) | Ilmentämisjärjestelmä kimeeristen monoklonaalisten vasta-aineiden tuottamiseksi | |
| DE3854502D1 (de) | Gegen hiv-antigene spezifischer monoklonaler antikörper. | |
| DK99682A (da) | Immunoanalysemetoder under anvendelse af monoklonale antistoffer | |
| ES551497A0 (es) | Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos de eimeria spp. | |
| DE69127487D1 (de) | Verfahren zum Nachweis der Alzheimer-Krankheit | |
| ES551495A0 (es) | Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos o merozoitos de eimeria spp. | |
| ES531436A0 (es) | Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos | |
| DE3689948D1 (de) | Monoklonale antikörper und testverfahren. | |
| FI902735A0 (fi) | Monoklonal antikropp reaktiv foer en visst vidstraeckt i olika maenskoleukemi- och lymfomaceller foerekommande antigen och metoder foer dess anvaendning i diagnos och vaord. | |
| DK0569537T3 (da) | Monoklonale antistoffer mod formodede HCV-kapperegioner og fremgangsmåder til anvendelse deraf | |
| GR3007000T3 (da) | ||
| ES522186A0 (es) | Metodo de ensayo de anticuerpos. | |
| DE3586808D1 (de) | L-thyroxin erkennende monoklonale antikoerper. | |
| DK0439048T3 (da) | Monoklonalt antistof, som genkender en anthracyclinglycosidspecifik epitop, og hybridoma, der udskiller dette antistof | |
| DK0556320T3 (da) | Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf | |
| NO834535L (no) | Fremgangsmaate for affinitetsrensing under anvendelse av monoklonale antistoffer. | |
| DK0677117T3 (da) | Sondring mellem HTLV-I og HTLV-II under anvendelse af syntetiske peptider | |
| DK651787A (da) | A-associerede h-antigener, monoklonale antistoffer, der er specifikke heroverfor, og fremgangsmaader til anvendelse af disse til blodtypebestemmelse | |
| BR9702101A (pt) | Hibridoma e anticorpo monoclonal |